Summit Therapeutics Stock Performance
as on September 26, 2026 at 2:16 pm IST
Day's Low
Day's High
$15.55$16.56
0.38%
Downside
6.09%
Upside
52 Week's Low
52 Week's High
$12.07$29.2322.68%
Downside
87.25%
Upside
Summit Therapeutics share price movements today
- Previous Close
- $16.38
- Open
- $16.45
- Volume
- 3.5M
- Market Cap
- $13.1B
- Day's Low - High
- $15.55 - $16.56
- 52 Week Low - High
- $12.07 - $29.23
Summit Therapeutics Historical Returns
- 1 Month Return
- + 9.7 %
- 3 Month Return
- + 11.42 %
- 1 Year Return
- -25.49 %
- 3 Year Return
- + 734.76 %
- 5 Year Return
- + 199.04 %
Summit Therapeutics Stock Fundamentals & Key Indicators
Check Summit Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$13.1B
EPS (TTM)
-1.12
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-14.62
Industry PE ratio
12.41
PEG Ratio
0.3117418203244143
EBITDA
-855.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-204.33%
Summit Therapeutics Stock Valuation
Track how Summit Therapeutics P/E has moved over time to understand its valuation trends.
Summit Therapeutics in the last 5 years
Lowest (-71.40x)
December 31, 2024
Today (-12.15x)
December 31, 2025
Industry (12.41x)
December 31, 2025
Highest (-2.63x)
December 31, 2023
Today’s Price to Earnings Ratio: -12.15x
Summit Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Summit Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $13.1B | 199.04% | -14.62 | 0.00% | 0.00% | |
| Neutral | $77.8B | -53.76% | -24.41 | -12.57% | 0.00% | |
| StrongBuy | $132.4B | 186.58% | 30.16 | 86.04% | 0.00% | |
| Buy | $82.8B | 23.34% | 19.01 | 84.86% | 0.46% |
Stock Returns calculator for Summit Therapeutics Stock including INR - Dollar returns
The Summit Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Summit Therapeutics investment value today
Current value as on today
₹80,488
Returns
Returns from Summit Therapeutics Stock
Dollar Impact
₹5,977 (+5.98%)
Analyst Recommendation on Summit Therapeutics Stock
Based on 11 analysts
63.64%
Buy
36.36%
Hold
0.00%
Sell
Based on 11 analysts, 63.63636363636363% of analysts recommend a 'BUY' rating for Summit Therapeutics. Average target price of $28.58
Summit Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Summit Therapeutics.
What analysts predicted
45.38%UPSIDE
Target Price
$28.58
Current Price
$15.61
Analyzed by
11 Analysts
High
$41
Target
$28.58
Low
$16
Summit Therapeutics target price $28.58, a slight upside of 45.38% compared to current price of $15.61. According to 11 analysts rating.
Indian Investors' Interest in Summit Therapeutics Stock
Investment in Summit Therapeutics Shares on INDmoney has dropped by -11.35% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Summit Therapeutics Stock has increased by 94% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:94% versus previous 30 day period
Summit Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Summit Therapeutics Annual Profit & Loss
All numbers in Millions USD
Summit Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Summit Therapeutics Annual Cash Flow
All numbers in Millions USD
Summit Therapeutics News & Key Events
Today's Timeline - 15 September
Tue, 06:50 PM
-Summit Therapeutics reports positive overall survival data from Phase III HARMONi trial for ivonescimab in lung cancer.
Insights on Summit Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, SMMT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 737.6%
NEGATIVE IMPACTPrice Dip
In the last 7 days, SMMT stock has moved down by -12.5%
About Summit Therapeutics
| Organisation | Summit Therapeutics |
| Headquarters | 601 Brickell Key Drive, Miami, FL, 33131, US |
| Industry | Biotechnology |
| CEO | Robert W. Duggan |
| E-voting on shares | Click here to vote |
Key Management of Summit Therapeutics
Name | Title |
|---|---|
Dr. Urte Gayko Ph.D. | Chief Regulatory, Quality & Pharmacovigilance Officer |
Mr. Manmeet Singh Soni CPA | COO, CFO & Director |
Dr. Elaine Carla Stracker J.D., Ph.D. | Chief Legal Officer |
Mr. Dave Gancarz CPA | Chief Business & Strategy Officer |
Mr. Bhaskar Anand | Chief Accounting Officer & Head of Finance |
Mr. Nathan LiaBraaten | Senior Director of Investor Relations |
Dr. Wang Clow Fong ScD | Chief Biometrics Officer |
Mr. Robert W. Duggan | Co-CEO & Executive Chairman |
Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-CEO, President & Director |
Prof. Kay Elizabeth Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
FAQs
What is Summit Therapeutics share price today?
Summit Therapeutics share price today is $15.61 as on at the close of the market. Summit Therapeutics share today touched a day high of $16.56 and a low of $15.55.
What is the 52 week high and 52 week low for Summit Therapeutics share?
Summit Therapeutics share touched a 52 week high of $29.23 on and a 52 week low of $12.07 on . Summit Therapeutics stock price today i.e. is closed at $15.61,which is 46.60% down from its 52 week high and 29.33% up from its 52 week low.
What is Summit Therapeutics's market capitalisation today?
Summit Therapeutics market capitalisation is $0.01T as on .
How to invest in Summit Therapeutics Stock (SMMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Summit Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Summit Therapeutics Shares that will get you 0.0961 shares as per Summit Therapeutics share price of $15.61 per share as on September 26, 2026 at 8:46 am IST.
What is the minimum amount required to buy Summit Therapeutics Stock (SMMT) from India?
Indian investors can start investing in Summit Therapeutics (SMMT) shares with as little as ₹95.819999694824 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.20 in Summit Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Summit Therapeutics share’s latest price of $15.61 as on September 26, 2026 at 8:46 am IST, you will get 0.6406 shares of Summit Therapeutics. Learn more about
fractional shares .
What are the returns that Summit Therapeutics has given to Indian investors in the last 5 years?
Summit Therapeutics stock has given 199.04% share price returns and 29.98% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?